Hot Products

1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside
Catalog No: CFN95096

Reference standards.

1,3,6-Tri-O-galloylglucose
Catalog No: CFN95043

1,3,6-Tri-O-galloylglucose shows anti-inflammatory activity.

1,3,7-Trihydroxy-2-prenylxanthone
Catalog No: CFN98022

1,3,7-Trihydroxy-2-prenylxanthone shows weak antibacterial activity against the bacterium.

1,3-Dicaffeoylquinic acid
Catalog No: CFN99123

1,3-Dicaffeoylquinic acid has neuroprotective, and antioxidant effects, it can prevent Aβ(42)-induced neurotoxicity through the activation of PI3K/Akt followed by the stimulation of Trk A, then the inhibition of GSK3β as well as the modulation of Bcl-2/Bax. 1,3-Dicaffeoylquinic acid has protective effects against MPP~+ induces neurotoxicity of PC12 Cells, it (50 umol/L) pretreatment can inhibit the MPP+-induced up-regulation of the expression of α-synuclein mRNA and protein.

1,3-Diphenyl-2-propen-1-one
Catalog No: CFN70227

1,3-Diphenyl-2-propen-1-one has anti-inflammatory, antifungal, antibacterial, antimalarial, antituberculosis, antitumor, antimicrobial and antiviral effects. It could be used to design effective inhibitors of alpha-amylase.

1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone
Catalog No: CFN97260

1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone has moderate cytotoxicities against breast cancer (MDA-MB-435S) and lung adenocarcinoma (A549) cell lines, but lacks antifungal activity against Candida albicans.

1,4,6-Trihydroxy-5-methoxy-7-prenylxanthone
Catalog No: CFN99675

Reference standards.

1,4-Cineole
Catalog No: CFN70116

1,4-Cineole presents potential anxiolytic-like action consistent with possible general depression of the CNS.

1,4-Dicaffeoylquinic acid
Catalog No: CFN99122

1,4-Dicaffeoylquinic acid is a potent and highly selective class of HIV-1 integrase inhibitors, inhibitsHIV-1 replication in MT-2 cell culture at non-toxic concentrations.1,4-Dicaffeoylquinic acid also has antioxidant activity.

1,5,15-Tri-O-methylmorindol
Catalog No: CFN97518

1,5,15-Tri-O-methylmorindol has effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by TPA.